FY21 consolidated facilities task order b (NCI-osfm-21-0056)
Ended Awarded Last action
- Contract number
- 75N91021F00005
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,541,397
Award facts
- Contract value 100% obligated
- $7,541,397.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $87,916 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $7,453,481 |
Show all 12
About this award
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., has been awarded a $7.5 million cost-plus-fixed-fee delivery order by the National Institutes of Health's National Cancer Institute to provide consolidated facilities support services at Fort Detrick, Maryland. Under the FY21 Consolidated Facilities Task Order B, Leidos will deliver operations, maintenance, and management of real property and grounds for the NIH NCI campus through September 2023. No subcontractors or set-aside designations were identified. The contract was awarded under the NIH's Consolidated Facilities Support Services IDIQ vehicle and will support the agency's ongoing biomedical research efforts relating to cancer prevention, diagnosis, and treatment.
Quick answers
Who was awarded contract 75N91021F00005?
75N91021F00005 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on April 12, 2021.
How much is contract 75N91021F00005 worth?
The government has obligated $7,541,397 on 75N91021F00005.
Is contract 75N91021F00005 an order under another contract?
Yes. 75N91021F00005 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00005 competed?
The extent of competition for 75N91021F00005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award